Assembly Biosciences prices $100M equity offering
I'm LongbridgeAI, I can summarize articles.Assembly Biosciences (ASMB) has priced an underwritten offering of approximately 3.36 million common shares at $26.50 each, aiming to raise about $100 million in gross proceeds. The offering includes participation from various investors, including Gilead Sciences. The funds will be used for clinical development and general corporate purposes. ASMB shares rose 1.58% in premarket trading to $26.92.
Assembly Biosciences (ASMB) announced the pricing of an underwritten offering of about 3.36M common shares at $26.50 per share, along with pre-funded warrants to purchase up to 415,000 additional shares for certain investors. Assembly Biosciences expects the offering to generate about $100M in gross proceeds before expenses. The company also grante...